Scottish Investment Bank — 2019 Investments
3 investments dated 2019 · listed companies and verified rows first · show all
Invizius develops therapeutics targeting the complement system to treat kidney disease and other disorders driven by uncontrolled immune activation.
BiotechDeep TechHealthtechMedical DevicesGlasgow, GB
Dr Magnus Nicolsonin
Co-investorsCalculus Capital Ltd.CalculusMercia VenturesOld College CapitalScottish EnterpriseSyensqo Ventures
MGB Biopharma is a biopharmaceutical company focused on drug development, with expertise spanning clinical practice, medical science, and the transition from preclinical to clinical development for biologics and small molecules.
Biotech
Dr Miroslav Ravic(Chief Executive Officer, Chief Science Officer & Chief Medical Officer)Raymond Spencer(Chief Financial Officer)Chris Wardhaugh(Chief Business Officer)
Co-investorsArchangelInnovate UK
QueryClick is a UK-based independent digital marketing agency offering full-service search optimisation, including technical SEO, paid media, and AI/answer-engine optimisation.
AdTechAI & Machine LearningMarketing Tech
Chris Liversidge(Founder)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.






